James Cassella
Director/Board Member bei TREVI THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von James Cassella
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 33 | |
| Private Company | Pharmaceuticals: Major | 25 | |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.
21
| Extinct | Pharmaceuticals: Major | 21 |
| Public Company | Biotechnology | 19 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von James Cassella
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Founder Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| VIVUS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Founder | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Graduate Degree Masters Business Admin | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Founder Corporate Officer/Principal | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
| Golden Gate University | College/University | Masters Business Admin Masters Business Admin | |
| Lehigh University | College/University | Undergraduate Degree Undergraduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Pepperdine University | College/University | Masters Business Admin Masters Business Admin | |
| San Jose State University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Linden Manager LLC
 Linden Manager LLC Investment ManagersFinance Linden Manager LLC (Linden Capital Partners) is a private equity firm founded in 2004 by Anthony B Davis and Brain C Miller. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 50 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 522 |
| Corporate Officer/Principal | 245 |
| Independent Dir/Board Member | 175 |
| Chairman | 84 |
| Undergraduate Degree | 83 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Suzanne H. Woolsey | 64 |
| Ed Mathers Mathers | 47 |
| Jonathan Leff | 45 |
| Ernest Mario | 44 |
| John Freund | 37 |
| Deepa Pakianathan | 32 |
| Alan Frazier | 31 |
| Harry Penner | 31 |
| Samuel D. Colella | 31 |
| Eran Broshy | 29 |
| Helmut Schühsler | 28 |
| Felix Baker | 28 |
| Meghan Fitzgerald | 28 |
| J. Read | 27 |
| J. Buchi | 26 |
- Börse
- Insiders
- James Cassella
- Unternehmensverbindungen
